Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page footer’s software/application revision indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the history. This is a page-version update rather than a change to trial content or results.SummaryDifference0.1%

- Check66 days agoChange DetectedA new version entry v3.4.3 was added and the previous version v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded revision label v3.4.2 and removed v3.4.1 from the history log.SummaryDifference0.1%

- Check95 days agoChange DetectedSanofi is now listed as sponsor/collaborators; Provention Bio is removed. The page history now includes a Study Status section.SummaryDifference0.8%

- Check96 days agoChange DetectedSponsor/Collaborators now lists Sanofi instead of Provention Bio, a Sanofi Company. The Study Status was updated as part of revision v3.4.1 (dated 2026-01-30).SummaryDifference0.8%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.